HBC(SH:603077) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2026-01-20 00:24Core Viewpoint - Sichuan Hebang Biotechnology Co., Ltd. is planning to recognize impairment provisions for various assets, which is expected to significantly reduce the net profit attributable to shareholders for the year 2025 by approximately 480 million to 580 million yuan, although the net profit excluding impairment effects remains positive [2][5]. Group 1: Impairment Provisions Overview - The company plans to recognize inventory impairment provisions ranging from 300 million to 380 million yuan due to the continuous decline in market prices for soda ash, ammonium chloride, glass, and photovoltaic products [2]. - Fixed assets and construction in progress are expected to incur impairment provisions of 220 million to 250 million yuan, while intangible assets are projected to have impairment provisions of 75 million to 85 million yuan, primarily due to an imbalance in supply and demand in the photovoltaic industry and strategic adjustments in related business [3]. - The company intends to recognize goodwill and related asset group impairment provisions of 55 million to 65 million yuan, following the requirements of accounting standards and considering the operational status and development expectations of the asset groups [4]. Group 2: Impact of Impairment Provisions - The impairment provisions are anticipated to reduce the net profit attributable to shareholders for 2025 by 480 million to 580 million yuan [5]. - The company expects a net profit attributable to shareholders for 2025 to be between -470 million and -570 million yuan, but excluding the impact of asset impairments, the net profit remains positive [10][12]. - The company also forecasts a net profit attributable to shareholders, excluding non-recurring gains and losses, to be between -460 million and -560 million yuan for 2025 [10]. Group 3: Main Business Impact - The company expects an increase in production and sales of liquid methionine and phosphate rock, with a recovery in market conditions for glyphosate and glufosinate, leading to improved gross margins for these products [19]. - However, the company faces ongoing challenges in the soda ash, glass, and photovoltaic sectors, resulting in increased inventory and sustained low prices, which have led to losses in these areas [19]. - The company plans to enhance profitability by increasing phosphate mining capacity and improving cost control measures for profitable products in 2026, following strategic adjustments to certain business operations [19].